United Therapeutics Corporation - Common Stock (NQ:UTHR)

461.82 -10.17 (-2.15%)

Streaming Delayed Price Updated: 12:53 PM EST, Jan 16, 2026 Add to My Watchlist

Price and Volume

Volume	131,249
Open	468.70
Bid (Size)	461.81 (80)
Ask (Size)	462.31 (240)
Prev. Close	471.99
Today's Range	461.45 - 470.08
52wk Range	266.98 - 519.99
Shares Outstanding	44,891,523
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Market-Beating Stocks to Target This Week

January 15, 2026

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the...

Via StockStory

Investment Advisor Doubles Down on Insurance Stock, According to Recent SEC Filing ↗

January 15, 2026

This specialty insurer delivers tailored property and casualty coverage for commercial and individual clients across diverse sectors.

Via The Motley Fool

Performance

YTD	-7.0%	-7.0%
1 Month	-7.6%	-7.6%
3 Month	+6.7%	+6.7%
6 Month	+55.3%	+55.3%
1 Year	+27.7%	+27.7%

More News

Nepsis Bets on CAVA's Future Growth Plan With $2.9 Million Purchase ↗

January 15, 2026

Via The Motley Fool

2 Cash-Heavy Stocks to Target This Week and 1 We Question

January 11, 2026

Via StockStory

United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 05, 2026

From United Therapeutics Corporation

Via Business Wire

Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers

December 21, 2025

Via StockStory

Why a $27 Million Buy Signals New Confidence in Weatherford Stock ↗

December 09, 2025

Via The Motley Fool

Signet Jewelers Gains New $25 Million Institutional Backer — Is the Stock a Buy? ↗

December 09, 2025

Via The Motley Fool

Why a Value Fund Has a $29 Million Bet on Core Natural Resources Stock ↗

December 09, 2025

Via The Motley Fool

Is Kulicke and Soffa Stock a Buy Even as One Fund Dumps a $10 Million Stake? ↗

December 09, 2025

Via The Motley Fool

United Therapeutics Corp (NASDAQ:UTHR): A Value Investing Case Study ↗

December 05, 2025

Via Chartmill

United Therapeutics Corp (NASDAQ:UTHR): A Caviar Cruise Quality Investment ↗

November 26, 2025

Via Chartmill

2 Mooning Stocks on Our Buy List and 1 That Underwhelm

November 21, 2025

Via StockStory

Here's How Much $100 Invested In United Therapeutics 15 Years Ago Would Be Worth Today ↗

November 19, 2025

Via Benzinga

United Therapeutics Corp (NASDAQ:UTHR) Presents a Compelling Value Investment Case ↗

November 12, 2025

Via Chartmill

3 Reasons Investors Love United Therapeutics (UTHR)

November 09, 2025

Via StockStory

Is United Therapeutics Corp Gaining or Losing Market Support? ↗

November 07, 2025

Via Benzinga

P/E Ratio Insights for United Therapeutics ↗

November 07, 2025

Via Benzinga

My Top Vanguard Index ETF Pick for 2026 ↗

November 06, 2025

Via The Motley Fool

The 5 Most Interesting Analyst Questions From United Therapeutics’s Q3 Earnings Call

November 05, 2025

Via StockStory

If You Invested $100 In United Therapeutics Stock 5 Years Ago, You Would Have This Much Today ↗

November 04, 2025

Via Benzinga

United Therapeutics Corporation to Present at Upcoming Investor Conferences

November 04, 2025

From United Therapeutics Corporation

Via Business Wire

United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease

November 03, 2025

From United Therapeutics Corporation

Via Business Wire

2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid

November 02, 2025

Via StockStory

United Therapeutics Corp (NASDAQ:UTHR) Offers Affordable Growth with Strong Profitability ↗

October 31, 2025

Via Chartmill

Frequently Asked Questions

Is United Therapeutics Corporation - Common Stock publicly traded?

Yes, United Therapeutics Corporation - Common Stock is publicly traded.

What exchange does United Therapeutics Corporation - Common Stock trade on?

United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for United Therapeutics Corporation - Common Stock?

The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market

What is the current price of United Therapeutics Corporation - Common Stock?

The current price of United Therapeutics Corporation - Common Stock is 461.82

When was United Therapeutics Corporation - Common Stock last traded?

The last trade of United Therapeutics Corporation - Common Stock was at 01/16/26 12:53 PM ET

What is the market capitalization of United Therapeutics Corporation - Common Stock?

The market capitalization of United Therapeutics Corporation - Common Stock is 20.73B

How many shares of United Therapeutics Corporation - Common Stock are outstanding?

United Therapeutics Corporation - Common Stock has 21B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.